Pipeline

As the U.S. rare disease affiliate of the family-owned global pharmaceutical company Italfarmaco, we are positioned to support the commercialization of products in Italfarmaco’s pipeline here in the United States. We are also actively seeking partners with high-quality assets backed by strong data so we can bring our focus, agility, speed and expertise to deliver real value for people living with rare diseases in need of treatment options.